EL7.AI
Mergers & AcquisitionsMedium•21 October 2026•
4 min read

HeartSciences files Fortitude merger proxy ahead of November 19 shareholder vote

Key Facts

1The shareholder meeting to vote on the merger will be held virtually on November 19, 2026 at 10 a.m. U.S. Eastern time.
2Fortitude announced an indicative, non-binding purchase commitment for mining equipment worth up to $100 million.
3The credit facility commitment to Fortitude increased from $50 million to $70 million.
4Fortitude reported revenue of $20.9 million and adjusted earnings before interest, taxes, depreciation and amortization of $8.5 million in the second quarter of 2026.

HeartSciences announced on October 21, 2026 that it had filed the definitive proxy statement for its proposed merger with Fortitude Mining, setting the stage for shareholders to vote on the deal. The company said in its statement that the filing with the U.S. Securities and Exchange Commission took place on October 19, before the move was announced to shareholders. The proxy concerns an all-stock merger with a digital asset mining company focused on Zcash. HeartSciences said its board "unanimously recommends that shareholders vote in favor" of the proposals related to the deal. Completion of the merger remains subject to shareholder approval, compliance with Nasdaq requirements and other closing conditions.

Fortitude is wholly owned by Digital Currency Group, according to HeartSciences' SEC filing, which also outlines some of the restructuring arrangements. The deal structure calls for HeartSciences to transfer most of its assets and liabilities to a subsidiary before completing the proposed merger. Fortitude had invested in HeartSciences through a private placement announced by the company in August 2026, ahead of the definitive proxy filing. Following that investment, Fortitude owned about 9.4% of HeartSciences' outstanding common shares, according to the latter's statement on the investment. HeartSciences confirmed that the share exchange ratio specified in the merger agreement had not changed as a result of Fortitude's investment.

HeartSciences' search for strategic alternatives came against a backdrop of sustained pressure on its shares, according to its explanation of the reasons for pursuing that course. The company also said it had faced repeated failures to comply with Nasdaq listing requirements, alongside limited liquidity for long-term planning. In its results for the first fiscal quarter of 2027, HeartSciences reported a net loss of about $3.2 million. That compared with a net loss of $2.1 million in the first fiscal quarter of 2026, according to the company's financial and operational update. HeartSciences said it recorded no material revenue in the first fiscal quarter of 2027.

Fortitude produced 72,696 units of Zcash during the six months ended June 30, 2026, according to figures published on HeartSciences' website. The company said that output represented about 28% of the currency's total network production over the same period. Fortitude reported revenue of $20.9 million in the second quarter of 2026. Its adjusted earnings before interest, taxes, depreciation and amortization totaled $8.5 million in that quarter, according to its financial and operational update. Its chief financial officer attributed the revenue performance to "continued performance of Zcash hashprice and hashrate across our fleet."

In October 2026, Fortitude announced an indicative, non-binding purchase commitment for next-generation Zcash mining equipment manufactured by Bitmain. The announced purchase commitment is worth up to $100 million, according to the company's statement on the new equipment supply arrangements. At the same time, Digital Currency Group increased its credit facility commitment to Fortitude from $50 million to $70 million. Fortitude said the increased credit facility commitment was intended to support potential investment in mining equipment as part of the supply announcement. The company expects shipments of the new Bitmain equipment to begin in the second quarter of 2027.

The next milestone for the merger is the virtual shareholder meeting scheduled for November 19, 2026, at 10 a.m. U.S. Eastern time. Shareholders of record on October 8, 2026 are entitled to vote at the meeting, according to HeartSciences' statement on voting procedures. The company said in its September update that it expected the deal to close in the fourth quarter of calendar 2026, subject to approvals and closing conditions. Following completion, the combined company is expected to operate under the Fortitude name, with its Class A common shares trading on Nasdaq under the ticker TUDE, subject to the exchange's approval. Jaime Leverton, who previously led Hut 8, is also expected to remain chief executive officer of the combined company after the deal closes.

Open on chart